These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 21045152)
1. Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer. Rahmanzadeh R; Rai P; Celli JP; Rizvi I; Baron-Lühr B; Gerdes J; Hasan T Cancer Res; 2010 Nov; 70(22):9234-42. PubMed ID: 21045152 [TBL] [Abstract][Full Text] [Related]
2. Light-Controlled Delivery of Monoclonal Antibodies for Targeted Photoinactivation of Ki-67. Wang S; Hüttmann G; Zhang Z; Vogel A; Birngruber R; Tangutoori S; Hasan T; Rahmanzadeh R Mol Pharm; 2015 Sep; 12(9):3272-81. PubMed ID: 26226545 [TBL] [Abstract][Full Text] [Related]
3. A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vitro. Xiao Z; McQuarrie SA; Suresh MR; Mercer JR; Gupta S; Miller GG J Biotechnol; 2002 Mar; 94(2):171-84. PubMed ID: 11796170 [TBL] [Abstract][Full Text] [Related]
4. Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel. Khayrani AC; Mahmud H; Oo AKK; Zahra MH; Oze M; Du J; Alam MJ; Afify SM; Quora HAA; Shigehiro T; Calle AS; Okada N; Seno A; Fujita K; Hamada H; Seno Y; Mandai T; Seno M Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818864 [TBL] [Abstract][Full Text] [Related]
5. Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis. Rahmanzadeh R; Hüttmann G; Gerdes J; Scholzen T Cell Prolif; 2007 Jun; 40(3):422-30. PubMed ID: 17531085 [TBL] [Abstract][Full Text] [Related]
6. The proliferation marker pKi-67 becomes masked to MIB-1 staining after expression of its tandem repeats. Schmidt MH; Broll R; Bruch HP; Duchrow M Histochem Cell Biol; 2002 Nov; 118(5):415-22. PubMed ID: 12432453 [TBL] [Abstract][Full Text] [Related]
7. Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. Bullwinkel J; Baron-Lühr B; Lüdemann A; Wohlenberg C; Gerdes J; Scholzen T J Cell Physiol; 2006 Mar; 206(3):624-35. PubMed ID: 16206250 [TBL] [Abstract][Full Text] [Related]
8. Isolation and comparative characterization of Ki-67 equivalent antibodies from the HuCAL phage display library. Jarutat T; Frisch C; Nickels C; Merz H; Knappik A Biol Chem; 2006 Jul; 387(7):995-1003. PubMed ID: 16913849 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Ki-67 antigen immunostaining (MIB-1 monoclonal antibody) in ovarian cancer. Mita S; Nakai A; Maeda S; Takeshita T J Nippon Med Sch; 2004 Dec; 71(6):384-91. PubMed ID: 15673959 [TBL] [Abstract][Full Text] [Related]
10. A light-controlled switch after dual targeting of proliferating tumor cells via the membrane receptor EGFR and the nuclear protein Ki-67. Wang S; Hüttmann G; Scholzen T; Zhang Z; Vogel A; Hasan T; Rahmanzadeh R Sci Rep; 2016 Jun; 6():27032. PubMed ID: 27246531 [TBL] [Abstract][Full Text] [Related]
11. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357 [TBL] [Abstract][Full Text] [Related]
12. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Key G; Becker MH; Baron B; Duchrow M; Schlüter C; Flad HD; Gerdes J Lab Invest; 1993 Jun; 68(6):629-36. PubMed ID: 7685843 [TBL] [Abstract][Full Text] [Related]
13. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction. Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053 [TBL] [Abstract][Full Text] [Related]
14. Indocyanine green as effective antibody conjugate for intracellular molecular targeted photodynamic therapy. Wang S; Hüttmann G; Rudnitzki F; Diddens-Tschoeke H; Zhang Z; Rahmanzadeh R J Biomed Opt; 2016 Jul; 21(7):78001. PubMed ID: 27424607 [TBL] [Abstract][Full Text] [Related]
15. A simple and general method for preparing antibody-PEG-PLGA sub-micron particles using electrospray technique: an in vitro study of targeted delivery of cisplatin to ovarian cancer cells. Bai MY; Liu SZ Colloids Surf B Biointerfaces; 2014 May; 117():346-53. PubMed ID: 24681046 [TBL] [Abstract][Full Text] [Related]
16. A p53-independent pathway regulates nucleolar segregation and antigen translocation in response to DNA damage induced by UV irradiation. Al-Baker EA; Boyle J; Harry R; Kill IR Exp Cell Res; 2004 Jan; 292(1):179-86. PubMed ID: 14720517 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte proliferation in lymphoid organs of the dromedary camel using the monoclonal antibody MIB-5 against the proliferation-associated nuclear epitope Ki-67. Zidan M; Pabst R Anat Histol Embryol; 2002 Oct; 31(5):286-9. PubMed ID: 12484421 [TBL] [Abstract][Full Text] [Related]
18. Detection of the Ki-67 proliferation associated nuclear epitope in normal canine tissues using the monoclonal antibody MIB-1. Laprie C; Abadie J; Amardeilh MF; Raymond I; Delverdier M Anat Histol Embryol; 1998 Aug; 27(4):251-6. PubMed ID: 9741148 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional organization of pKi-67: a comparative fluorescence and electron tomography study using FluoroNanogold. Cheutin T; O'Donohue MF; Beorchia A; Klein C; Kaplan H; Ploton D J Histochem Cytochem; 2003 Nov; 51(11):1411-23. PubMed ID: 14566014 [TBL] [Abstract][Full Text] [Related]
20. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer. Rudolph P; Alm P; Heidebrecht HJ; Bolte H; Ratjen V; Baldetorp B; Fernö M; Olsson H; Parwaresch R J Natl Cancer Inst; 1999 Feb; 91(3):271-8. PubMed ID: 10037106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]